[Home ] [Archive]    
:: Main About Current Issue Archive Search Submit Contact ::
:: Volume 4, Issue 2 (October 2018) ::
RABMS 2018, 4(2): 81-90 Back to browse issues page
Nanobodies: emerging tools for clinical applications
Ali Aghebati-Maleki , Leila Aghebati-Maleki
Department of Genetics and Molecular Medicine, School of Medicine, Zanjan University of Medical Sciences (ZUMS), Zanjan, Iran , ali.aghebati.maleki@gmail.com
Abstract:   (627 Views)
Since the introduction of heavy-chain antibodies (HcAbs) two decades ago and the explanation of nanobodies, valuable biochemical properties of nanobodies have generated the interest of researchers on their use in diagnosis and therapy of tumor. Various specific nanobodies (VHHs or sdAbs) have been selected from library and detected high affinity with their antigens. The small size of nanobodies (~15 kDa, 4 nm long and 2.5 nm wide) make it easy for them to penetrate the tissue or get through the blood brain barrier as drugs.  Furthermore, nanobodies have been offered in conjugates with other effector domains and in drug delivery systems as targeting for tumors. The nanobodies has the potential to make effective biomedical carriers in the fields of research, diagnostics and therapy. In this review we have explained the important advances in the field of nanobodies. Nevertheless, there are many potentials to further develop and improve nanobody-mediated tumor targeting. In the near future, new targets and their corresponding nanobodies must be identified. Currently, some researchers exploited available nanobodies against tumor-specific receptors for delivering drugs or toxins to tumors, therewith reducing nonspecific toxicity to normal cells and lessening side effects. In conclusion, nanobodies as targeting carrier appear to be a promising method of tumor targeting therapy and diagnosis.
 
Keywords: Nanobodies, tumor targeting, clinical applications
Full-Text [PDF 1044 kb]   (361 Downloads)    
Type of Study: orginal article | Subject: Special
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Aghebati-Maleki A, Aghebati-Maleki L. Nanobodies: emerging tools for clinical applications. RABMS. 2018; 4 (2) :81-90
URL: http://ijrabms.umsu.ac.ir/article-1-74-en.html


Volume 4, Issue 2 (October 2018) Back to browse issues page
Journal of Research in Applied and Basic Medical Sciences
Persian site map - English site map - Created in 0.05 seconds with 32 queries by YEKTAWEB 4212